Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

Condition:   Type 2 Diabetes Treated With Insulin Interventions:   Drug: Insulin glargine;   Drug: NovoLog;   Drug: Insulin Fiasp;   Other: Standard carbohydrate diet Sponsors:   Boston Medical Center;   Novo Nordisk A/S Not yet recruiting

Source: ClinicalTrials.gov - July 7, 2020 Category: Research Source Type: clinical trials